Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips
Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips
复制标题
DOI：
10.1016/j.jinf.2006.05.012
复制
发表时间：
2007-03-01
影响因子：
28.2
通讯作者：
Shinnick, Thomas M.
中科院分区：
文献类型：
--
作者：
Fu, Li M.;Shinnick, Thomas M.
Objective: Multi-drug resistance and latent infection are two major issues in current tuberculosis (TB) control and management. Capreomycin is an important drug used for TB with multi-drug resistance. A recent study also indicates that this drug possesses unique bactericidal activity against non-replicating TB bacilli among known anti-TB drugs. Thus, there is an urgent need for investigating the full-spectrum action of capreomycin.Methods: Here we conduct the first microarray-based study on capreomycin using the high-resolution Affymetrix oligonucleotide GeneChip system.Results: The results indicate that capreomycin primarily acts on the information pathways but it also significantly affects cell wait, cell processes, intermediate metabolism and respiration in Mycobacterium tuberculosis.Conclusions: This study not only transcriptionally validates the specific molecular target, 16S rRNA, but also discovers potential new targets of capreomycin, including genes operating at the DNA Level, such as Rv0054 (ssb) and Rv3715c (recR), as well as genes involved in cell division like Rv3260c (whiB2). In addition, the nuo gene cluster and the ATP synthase gene cluster are repressed. (C) 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
